Telum Therapeutics
Barcelona, Spain· Est. 2018
Develops antibody-based therapies targeting bacterial infections, focusing on antimicrobial resistance.
Private Company
Total funding raised: $2M
About
Develops antibody-based therapies targeting bacterial infections, focusing on antimicrobial resistance.
Microbiome
Funding History
1Total raised:$2M
Seed$2MJun 15, 2022